Cluster of overdoses linked to counterfeit drugs

“Extreme caution” has been urged by the HSE following a number of overdoses related to the circulation of counterfeit drugs containing strong, synthetic opioids.

A cluster of overdoses were detected in Dublin, Galway and the midwest.

Nitazene, described by the HSE as a potent and dangerous synthetic opioid, in yellow, round counterfeit benzodiazepine tablets has been associated with the overdoses, analysis by the Emerging Trends Laboratory at the HSE National Drug Treatment Centre found.

Ongoing analysis will work to identify the exact composition of the substance.

“These pose a substantial risk of overdose, hospitalisation and death,” HSE Clinical Lead in Addiction Services Professor Eamon Keenan said.

To avoid the “extra risk”, the advice from the HSE is to avoid taking these tablets, new batches of drugs, new type of drugs or obtaining drugs from new sources.

It has also recommended that people talk to a local service or doctor about accessing naloxone, a medication used to reverse the effects of opiate-type drugs, for free, and to seek medical help if signs of overdose are detected.

Due to the rise in overdoses, the HSE is working with various partners to monitor the situation.